30 min
Episode 178: Hidradenitis Suppurativa Learn Skin with Dr. Raja and Dr. Hadar
-
- Medicine
Looking for some optimism around HS treatments? We’ve got it here. This week, we’re joined by Dr. Joslyn Kirby as she shares her experience in working with HS and talks the nuts and bolts of HS with diagnosis, pathogenesis, and novel treatment options coming down the pipeline. Each Thursday, join Dr. Raja and Dr. Hadar, board-certified dermatologists, as they share the latest evidence-based research in integrative dermatology. To learn more about HS and earn free CME credits, visit LearnSkin.com to enroll in the HS: Examining the Role of Immunology and Inflammation with Biologics and JAK Inhibition series.
Dr. Joslyn Kirby is a Professor of Dermatology at Penn State Hershey and Past President of the Hidradenitis Suppurativa Foundation. In clinic and through her research, she is focused on hidradenitis suppurativa, including its effects on people and outcome measurement.
Supported by independent educational grants from Incyte and UCB
Looking for some optimism around HS treatments? We’ve got it here. This week, we’re joined by Dr. Joslyn Kirby as she shares her experience in working with HS and talks the nuts and bolts of HS with diagnosis, pathogenesis, and novel treatment options coming down the pipeline. Each Thursday, join Dr. Raja and Dr. Hadar, board-certified dermatologists, as they share the latest evidence-based research in integrative dermatology. To learn more about HS and earn free CME credits, visit LearnSkin.com to enroll in the HS: Examining the Role of Immunology and Inflammation with Biologics and JAK Inhibition series.
Dr. Joslyn Kirby is a Professor of Dermatology at Penn State Hershey and Past President of the Hidradenitis Suppurativa Foundation. In clinic and through her research, she is focused on hidradenitis suppurativa, including its effects on people and outcome measurement.
Supported by independent educational grants from Incyte and UCB
30 min